Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)

NCT01008813 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

306

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: adjuvanted A(H1N1)v influenza vaccine
BIOLOGICAL: non-adjuvanted A(H1N1)v influenza vaccine

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis

Collaborators

[object Object]